Visualitza per autor "Vassena, Rita"

Ordena per: Ordre: Resultats:

  • Rodríguez Pizà, Ignasi; Verma, Inder M.; Veiga, Anna; Aasen, Trond; Izpisúa Belmonte, J. C.; Bueren, Juan; Garreta, Elena; Tiscornia, Gustavo; Sleep Ronquillo, Eduard; Raya Chamorro, Ángel; Río, Paula; Consiglio, Antonella; Barrero Núñez, María José; Navarro, Susana; Vassena, Rita; Guenechea, Guillermo (Nature Publishing Group, 2009)
    The generation of induced pluripotent stem (iPS) cells has enabled the derivation of patient-specific pluripotent cells and/nprovided valuable experimental platforms to model human disease. Patient-specific iPS cells are ...
  • Montserrat, Nuria; Oñate Monje, Lorena de, 1985-; Garreta, Elena; González, Federico; Adamo, Antonio; Eguizábal, Cristina; Häfner, Sophia; Vassena, Rita; Izpisúa Belmonte, J. C. (Cognizant Communication Corporation, 2012)
    The pig represents an ideal large-animal model, intermediate between rodents and humans, for the preclinical assessment of emerging cell therapies. As no validated pig embryonic stem (pES) cell lines have been derived so ...
  • Rodríguez Pizà, Ignasi; Barragan, Montserrat; González, Federico; Izpisúa Belmonte, J. C.; Batlle Morera, Laura; Vassena, Rita; Montserrat, Nuria; Tiscornia, Gustavo (National Academy of Sciences, 2009)
    Induced pluripotent stem (iPS) cells have generated keen interest/ndue to their potential use in regenerative medicine. They have/nbeen obtained from various cell types of both mice and humans by/nexogenous delivery of ...
  • Rodríguez Pizà, Ignasi; Vassena, Rita; Richaud Patin, Yvonne; Izpisúa Belmonte, J. C.; Raya Chamorro, Ángel; Veiga, Anna; Barrero Núñez, María José; González, Federico (AlphaMed Press and Wiley-Blackwell, 2010)
    The availability of induced pluripotent stem cells (iPSCs)/nhas created extraordinary opportunities for modeling and/nperhaps treating human disease. However, all reprogramming/nprotocols used to date involve the use of ...